Follow the people · Insider
Carl Dambkowski
Carl Dambkowski files insider transactions with the SEC as a chief medical officer of Apogee Therapeutics (APGE). We hold 12 disclosed purchases and sales filed since 20 December 2023, 5 of them in the last 90 days.
- Files forAPGE
- Disclosed buys and sells12 in all, 5 in the last 90 days
- Last disclosure3 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 December 2023 — 3 September 2026Chief Medical Officer · Apogee Therapeutics (APGE)113 Form 4 lines · source: SEC Form 4
- Filed 2 June 2025 — 12 June 2026Director · Oruka Therapeutics (ORKA)15 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- returned to the issuer 1,375 shares of Apogee TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- returned to the issuer 167,123 shares of Apogee TherapeuticsSEC Form 43 September 2026Common Stock · traded 3 September 2026 · filed 3 September 2026
- returned to the issuer 110,665 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 September 2026Stock Option (Right to Buy) · traded 3 September 2026 · filed 3 September 2026
- returned to the issuer 124,962 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 September 2026Stock Option (Right to Buy) · traded 3 September 2026 · filed 3 September 2026
- returned to the issuer 83,690 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 September 2026Stock Option (Right to Buy) · traded 3 September 2026 · filed 3 September 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 47 August 2026Common Stock · traded 5 August 2026 · filed 7 August 2026
- ▼ sold on the open market 5,500 shares of Apogee TherapeuticsSEC Form 47 August 2026Common Stock · traded 5 August 2026 · filed 7 August 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 47 August 2026Stock Option (Right to Buy) · traded 5 August 2026 · filed 7 August 2026
- gave away 8,000 shares of Apogee TherapeuticsSEC Form 416 July 2026Common Stock · traded 14 July 2026 · filed 16 July 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 5,500 shares of Apogee TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 42 July 2026Stock Option (Right to Buy) · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 26,400 shares of Apogee TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 22,417 shares of Oruka TherapeuticsSEC Form 412 June 2026Common Stock · traded 11 June 2026 · filed 12 June 2026
- ▼ sold on the open market 12,583 shares of Oruka TherapeuticsSEC Form 412 June 2026Common Stock · traded 12 June 2026 · filed 12 June 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- ▼ sold on the open market 5,500 shares of Apogee TherapeuticsSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 45 June 2026Stock Option (Right to Buy) · traded 3 June 2026 · filed 5 June 2026
- was granted 9,136 shares of Oruka Therapeutics (a derivative holding)SEC Form 43 June 2026Stock Option (right to buy) · traded 2 June 2026 · filed 3 June 2026
- exercised options over 38,689 shares of Oruka TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- exercised options over 11,904 shares of Oruka TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- exercised options over 11,667 shares of Oruka TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- ▼ sold on the open market 38,318 shares of Oruka TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- ▼ sold on the open market 53,447 shares of Oruka TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- ▼ sold on the open market 13,235 shares of Oruka TherapeuticsSEC Form 422 May 2026Common Stock · traded 21 May 2026 · filed 22 May 2026
- exercised options over 38,689 shares of Oruka Therapeutics (a derivative holding)SEC Form 422 May 2026Stock Option (right to buy) · traded 21 May 2026 · filed 22 May 2026
- exercised options over 11,904 shares of Oruka Therapeutics (a derivative holding)SEC Form 422 May 2026Warrant (right to buy) · traded 21 May 2026 · filed 22 May 2026
- exercised options over 11,667 shares of Oruka Therapeutics (a derivative holding)SEC Form 422 May 2026Stock Option (right to buy) · traded 21 May 2026 · filed 22 May 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 48 May 2026Common Stock · traded 6 May 2026 · filed 8 May 2026
- ▼ sold on the open market 3,700 shares of Apogee TherapeuticsSEC Form 48 May 2026Common Stock · traded 6 May 2026 · filed 8 May 2026
- ▼ sold on the open market 1,800 shares of Apogee TherapeuticsSEC Form 48 May 2026Common Stock · traded 6 May 2026 · filed 8 May 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 48 May 2026Stock Option (Right to Buy) · traded 6 May 2026 · filed 8 May 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 2,698 shares of Apogee TherapeuticsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 2,702 shares of Apogee TherapeuticsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 100 shares of Apogee TherapeuticsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 April 2026Stock Option (Right to Buy) · traded 1 April 2026 · filed 3 April 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 3,225 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 2,075 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 46 March 2026Stock Option (Right to Buy) · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 200 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 46 March 2026Stock Option (Right to Buy) · traded 4 March 2026 · filed 6 March 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 3,225 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 2,075 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 200 shares of Apogee TherapeuticsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 2,481 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,420 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (Right to Buy) · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,299 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 100 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 200 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- exercised options over 4,125 shares of Apogee Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (Right to Buy) · traded 4 February 2026 · filed 4 February 2026
- exercised options over 4,125 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 2,481 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,420 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 1,299 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 100 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- ▼ sold on the open market 200 shares of Apogee TherapeuticsSEC Form 44 February 2026Common Stock · traded 4 February 2026 · filed 4 February 2026
- acquired or disposed of, other 116,483 shares of Oruka TherapeuticsSEC Form 423 January 2026Common Stock · traded 23 January 2026 · filed 23 January 2026
- acquired or disposed of, other 116,483 shares of Oruka TherapeuticsSEC Form 423 January 2026Common Stock · traded 23 January 2026 · filed 23 January 2026
- exercised options over 14,025 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 2,954 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 14,820 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- exercised options over 14,025 shares of Apogee Therapeutics (a derivative holding)SEC Form 49 January 2026Stock Option (Right to Buy) · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 826 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 100 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- exercised options over 14,025 shares of Apogee Therapeutics (a derivative holding)SEC Form 49 January 2026Stock Option (Right to Buy) · traded 7 January 2026 · filed 9 January 2026
- exercised options over 14,025 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 2,954 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 14,820 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 826 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- ▼ sold on the open market 100 shares of Apogee TherapeuticsSEC Form 49 January 2026Common Stock · traded 7 January 2026 · filed 9 January 2026
- was granted 83,690 shares of Apogee Therapeutics (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 83,690 shares of Apogee Therapeutics (a derivative holding)SEC Form 46 January 2026Stock Option (Right to Buy) · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 10,900 shares of Apogee TherapeuticsSEC Form 45 December 2025Common Stock · traded 4 December 2025 · filed 5 December 2025
- exercised options over 8,060 shares of Apogee Therapeutics (a derivative holding)SEC Form 47 November 2025Stock Option (Right to Buy) · traded 5 November 2025 · filed 7 November 2025
- exercised options over 8,060 shares of Apogee TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 2,300 shares of Apogee TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 2,200 shares of Apogee TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 5,607 shares of Apogee TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- ▼ sold on the open market 678 shares of Apogee TherapeuticsSEC Form 47 November 2025Common Stock · traded 5 November 2025 · filed 7 November 2025
- exercised options over 2,385 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 October 2025Stock Option (Right to Buy) · traded 1 October 2025 · filed 3 October 2025
- exercised options over 2,385 shares of Apogee TherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- ▼ sold on the open market 5,110 shares of Apogee TherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- ▼ sold on the open market 2,535 shares of Apogee TherapeuticsSEC Form 45 September 2025Common Stock · traded 3 September 2025 · filed 5 September 2025
- ▼ sold on the open market 190 shares of Apogee TherapeuticsSEC Form 45 September 2025Common Stock · traded 3 September 2025 · filed 5 September 2025
- ▼ sold on the open market 2,725 shares of Apogee TherapeuticsSEC Form 48 August 2025Common Stock · traded 6 August 2025 · filed 8 August 2025
- exercised options over 7,365 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 July 2025Stock Option (Right to Buy) · traded 2 July 2025 · filed 3 July 2025
- exercised options over 7,365 shares of Apogee TherapeuticsSEC Form 43 July 2025Common Stock · traded 2 July 2025 · filed 3 July 2025
- ▼ sold on the open market 6,409 shares of Apogee TherapeuticsSEC Form 43 July 2025Common Stock · traded 2 July 2025 · filed 3 July 2025
- ▼ sold on the open market 2,935 shares of Apogee TherapeuticsSEC Form 43 July 2025Common Stock · traded 2 July 2025 · filed 3 July 2025
- ▼ sold on the open market 746 shares of Apogee TherapeuticsSEC Form 43 July 2025Common Stock · traded 2 July 2025 · filed 3 July 2025
- ▼ sold on the open market 2,725 shares of Apogee TherapeuticsSEC Form 46 June 2025Common Stock · traded 4 June 2025 · filed 6 June 2025
- was granted 17,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 43 June 2025Stock Option (right to buy) · traded 2 June 2025 · filed 3 June 2025
- ▼ sold on the open market 2,725 shares of Apogee TherapeuticsSEC Form 49 May 2025Common Stock · traded 7 May 2025 · filed 9 May 2025
- ▼ sold on the open market 2,471 shares of Apogee TherapeuticsSEC Form 44 April 2025Common Stock · traded 2 April 2025 · filed 4 April 2025
- ▼ sold on the open market 500 shares of Apogee TherapeuticsSEC Form 44 April 2025Common Stock · traded 2 April 2025 · filed 4 April 2025
- ▼ sold on the open market 889 shares of Apogee TherapeuticsSEC Form 44 April 2025Common Stock · traded 2 April 2025 · filed 4 April 2025
- ▼ sold on the open market 1,590 shares of Apogee TherapeuticsSEC Form 47 March 2025Common Stock · traded 5 March 2025 · filed 7 March 2025
- exercised options over 795 shares of Apogee Therapeutics (a derivative holding)SEC Form 47 February 2025Stock Option (Right to Buy) · traded 5 February 2025 · filed 7 February 2025
- exercised options over 795 shares of Apogee TherapeuticsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- ▼ sold on the open market 3,520 shares of Apogee TherapeuticsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- exercised options over 1,360 shares of Apogee Therapeutics (a derivative holding)SEC Form 43 January 2025Stock Option (Right to Buy) · traded 2 January 2025 · filed 3 January 2025
- exercised options over 1,360 shares of Apogee TherapeuticsSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- ▼ sold on the open market 1,499 shares of Apogee TherapeuticsSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- ▼ sold on the open market 2,486 shares of Apogee TherapeuticsSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- ▼ sold on the open market 100 shares of Apogee TherapeuticsSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- exercised options over 1,815 shares of Apogee Therapeutics (a derivative holding)SEC Form 413 December 2024Stock Option (Right to Buy) · traded 11 December 2024 · filed 13 December 2024
- exercised options over 1,815 shares of Apogee TherapeuticsSEC Form 413 December 2024Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 4,085 shares of Apogee TherapeuticsSEC Form 413 December 2024Common Stock · traded 11 December 2024 · filed 13 December 2024
- ▼ sold on the open market 455 shares of Apogee TherapeuticsSEC Form 413 December 2024Common Stock · traded 11 December 2024 · filed 13 December 2024
- was granted 124,962 shares of Apogee Therapeutics (a derivative holding)SEC Form 411 December 2024Stock Option (Right to Buy) · traded 9 December 2024 · filed 11 December 2024
- ▼ sold on the open market 6,665 shares of Apogee TherapeuticsSEC Form 46 December 2024Common Stock · traded 4 December 2024 · filed 6 December 2024
- ▼ sold on the open market 5,326 shares of Apogee TherapeuticsSEC Form 48 November 2024Common Stock · traded 6 November 2024 · filed 8 November 2024
- ▼ sold on the open market 1,339 shares of Apogee TherapeuticsSEC Form 48 November 2024Common Stock · traded 6 November 2024 · filed 8 November 2024
- ▼ sold on the open market 5,740 shares of Apogee TherapeuticsSEC Form 44 October 2024Common Stock · traded 2 October 2024 · filed 4 October 2024
- ▼ sold on the open market 925 shares of Apogee TherapeuticsSEC Form 44 October 2024Common Stock · traded 2 October 2024 · filed 4 October 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.